A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease
PROTOB
Effect of a Whey Protein Supplementation on Intrahepatic Lipids in Obese Patients With Non-alcoholic Fatty Liver Disease
1 other identifier
interventional
11
1 country
1
Brief Summary
An increase in dietary protein intake has been shown to blunt the increase in intrahepatic fat induced by high fat feeding in healthy individuals. The purpose of this study is to determine if a protein supplementation decreases intrahepatic fat in obese patients with non-alcoholic fatty liver disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2009
CompletedFirst Posted
Study publicly available on registry
March 26, 2009
CompletedStudy Start
First participant enrolled
April 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2010
CompletedFebruary 24, 2012
February 1, 2012
8 months
March 25, 2009
February 23, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
intrahepatic fat
before and after 4 weeks of whey protein supplementation
Secondary Outcomes (2)
glucose metabolism
4-hour oral glucose tolerance test with indirect calorimetry
body weight and body fat
before and after 4 weeks whey protein supplementation
Study Arms (1)
1
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- BMI higher than 35 kg/m2
- age 18-50 years
- sex male or female
- ASAT/ALAT \> 1.8
You may not qualify if:
- treatment with hypolemic or antidiabetic agents
- blood glucose \> 7 mmol/l
- alcohol intake \> 20g/day
- creatinin \> 120 umol/l)
- contra-indications to Magnetic resonnance imaging
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre d'investigations cliniques "cardiomet"/ CHUV
Lausanne, Canton of Vaud, CH-1011, Switzerland
Related Publications (1)
Bortolotti M, Maiolo E, Corazza M, Van Dijke E, Schneiter P, Boss A, Carrel G, Giusti V, Le KA, Quo Chong DG, Buehler T, Kreis R, Boesch C, Tappy L. Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients. Clin Nutr. 2011 Aug;30(4):494-8. doi: 10.1016/j.clnu.2011.01.006. Epub 2011 Feb 1.
PMID: 21288612DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luc Tappy, MD
Centre Hospitalier Universitaire Vaudois
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor of physiology
Study Record Dates
First Submitted
March 25, 2009
First Posted
March 26, 2009
Study Start
April 1, 2009
Primary Completion
December 1, 2009
Study Completion
April 1, 2010
Last Updated
February 24, 2012
Record last verified: 2012-02